Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma

Published:2012-10-08 Issue:36 Volume:32 Page:4231-4242
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Barbarulo A,Iansante V,Chaidos A,Naresh K,Rahemtulla A,Franzoso G,Karadimitris A,Haskard D O,Papa S,Bubici C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2012448.pdf

Reference54 articles.

1. Anderson KC, Carrasco RD . Pathogenesis of myeloma. Annu Rev Pathol 2011; 6: 249–274.

2. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC . Multiple myeloma. Lancet 2009; 374: 324–339.

3. Rajkumar SV . Treatment of multiple myeloma. Nat Rev Clin Oncol 2011; 8: 479–491.

4. Hallek M, Bergsagel PL, Anderson KC . Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21.

5. Witzig TE, Timm M, Larson D, Therneau T, Greipp PR . Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders. Br J Haematol 1999; 104: 131–137.

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multidomain PARP14 construct suitable for bacterial expression;Protein Expression and Purification;2024-12

2. Body‐wide genetic deficiency of poly(ADP‐ribose) polymerase 14 sensitizes mice to colitis;The FASEB Journal;2024-07-05

3. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein–Protein Interactions to Promote Cancer Cell Survival;Journal of Molecular Biology;2024-02

4. Body-wide genetic deficiency of poly(ADP-ribose) polymerase 14 sensitizes mice to colitis;2024-01-15

5. PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology;Expert Reviews in Molecular Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3